Lothar Burghaus
Overview
Explore the profile of Lothar Burghaus including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
405
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Winter Y, Mayer G, Benes H, Burghaus L, Floam S, Parks G, et al.
Sleep Breath
. 2025 Feb;
29(1):112.
PMID: 40014191
Purpose: Solriamfetol is approved for use in the European Union to treat excessive daytime sleepiness (EDS) associated with obstructive sleep apnea (OSA). SURWEY characterized real-world evidence regarding physician initiation and...
2.
Schroeder J, Schlesinger A, Burghaus L, Pape P, Balke M
J Travel Med
. 2024 Feb;
31(6).
PMID: 38340321
No abstract available.
3.
Burghaus L, Madlener M, Kohle F, Bruno E, Limmroth V, Fink G, et al.
J Clin Neurol
. 2023 Jul;
19(4):365-370.
PMID: 37417432
Background And Purpose: Status epilepticus (SE) is a neurological emergency due to prolonged seizure activity or multiple seizures without full recovery in between them. Prehospital SE management is crucial since...
4.
Kohle F, Madlener M, Bruno E, Fink G, Limmroth V, Burghaus L, et al.
Seizure
. 2023 Apr;
107:114-120.
PMID: 37004393
Objective: To explore the reasons for and outcomes of non- or undertreatment with benzodiazepines (BZDs) in status epilepticus (SE). Methods: We retrospectively analysed all SE patients from the urban area...
5.
Winter Y, Mayer G, Kotterba S, Benes H, Burghaus L, Koch A, et al.
Sleep Med
. 2023 Feb;
103:138-143.
PMID: 36796288
Background: Excessive daytime sleepiness (EDS) is a core narcolepsy symptom, for which solriamfetol (Sunosi®) was recently approved in the European Union. SURWEY characterises real-world strategies used by physicians when initiating...
6.
Votteler S, Knaack L, Janicki J, Fink G, Burghaus L
Sleep Med
. 2022 Dec;
101:429-436.
PMID: 36516599
Background And Purpose: Sex differences in the clinical findings and the polysomnographic presentation of patients with obstructive sleep apnea (OSA) are compelling current research issues. For example, patients suffering from...
7.
Kohle F, Madlener M, Bruno E, Fink G, Limmroth V, Burghaus L, et al.
J Neurol
. 2022 Jul;
269(11):5710-5719.
PMID: 35802201
Background: The "coronavirus disease 2019" (COVID-19) pandemic, caused by the "severe-acute-respiratory-syndrome-coronavirus 2" (SARS-CoV-2), challenges healthcare systems worldwide and impacts not only COVID-19 patients but also other emergencies. To date, data...
8.
Madlener M, Onur O, Muller-Ehmsen J, Fink G, Burghaus L
Fortschr Neurol Psychiatr
. 2022 May;
90(12):571-579.
PMID: 35508194
Acute aortic dissection is rare but life-threatening. The symptoms depend on the localization and reduced perfusion of the downstream organs or limbs and are therefore variable. Neurological symptoms may occur...
9.
Golla H, Dillen K, Hellmich M, Dojan T, Ungeheuer S, Schmalz P, et al.
BMJ Open
. 2022 Jan;
12(1):e049300.
PMID: 35078833
Introduction: Patients with multiple sclerosis (MS) have complex needs that range from organising one's everyday life to measures of disease-specific therapy monitoring to palliative care. Patients with MS are likely...
10.
Burghaus L, Piano L, Fink G, Knaack L
Sleep Breath
. 2020 Oct;
25(3):1555-1557.
PMID: 33089399
No abstract available.